Description - Nuclear Receptors as Drug Targets, Volume 39 by Eckhard Ottow
Edited by two experts working at the pioneering pharmaceutical company and major global player in hormone-derived drugs, this handbook and reference systematically treats the drug development aspects of all human nuclear receptors, including recently characterized receptors such as PPAR, FXR and LXR. Authors from leading pharmaceutical companies around the world present examples and real-life data from their own work.
Buy Nuclear Receptors as Drug Targets, Volume 39 by Eckhard Ottow from Australia's Online Independent Bookstore, Boomerang Books.
(248mm x 179mm x 31mm)
Wiley-VCH Verlag GmbH
Publisher: John Wiley and Sons Ltd
Country of Publication:
Book Reviews - Nuclear Receptors as Drug Targets, Volume 39 by Eckhard Ottow
Author Biography - Eckhard Ottow
Eckard Ottow is the head of medicinal chemistry at Schering AG in Berlin (Germany). He studied Chemistry at the University of Hannover (Germany) and received his PhD degree in 1982. He joined Schering AG in 1983, first in the field of endocrinology and later in oncology and CNS. In 2002, he was appointed to his present position as head of medicinal chemistry. He is also a honorary professor at the Technical University of Berlin. Hilmar Weinmann studied Chemistry at the universities of Tubingen and Hannover (Germany). He joined Schering in 1995, where he is currently a department head of Medicinal Chemistry. His main fields of expertise are in oncology, dermatology and gender healthcare.